NCT01294059View on ClinicalTrials.gov

Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Fibromyalgia
Interventions
DRUG

Milnacipran

50 mg BID Oral x 6 Weeks

Trial Locations (1)

32610

Center for Musculoskeletal Pain Research, Gainesville

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

University of Florida

OTHER

NCT01294059 - Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients | Biotech Hunter | Biotech Hunter